CD8A and neoplasm: Notably, the data from murine models are in line with those from patients in which the representative IHC analysis performed on tumor biopsies from ECM3 + and ECM3- patients clearly revealed a reduction in CD8 + T cells in ECM3 + tumors (Fig. 3 J).